FRANCO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.993
AS - Asia 1.404
EU - Europa 1.065
SA - Sud America 193
Continente sconosciuto - Info sul continente non disponibili 102
AF - Africa 96
OC - Oceania 9
Totale 4.862
Nazione #
US - Stati Uniti d'America 1.924
CN - Cina 500
SG - Singapore 356
IE - Irlanda 264
VN - Vietnam 217
HK - Hong Kong 168
RU - Federazione Russa 166
IT - Italia 139
BR - Brasile 135
DE - Germania 116
FI - Finlandia 104
FR - Francia 70
ZA - Sudafrica 70
GB - Regno Unito 49
UA - Ucraina 35
IN - India 33
CA - Canada 30
BD - Bangladesh 27
CZ - Repubblica Ceca 21
MX - Messico 21
BE - Belgio 18
SE - Svezia 16
AR - Argentina 14
CO - Colombia 13
NL - Olanda 13
JP - Giappone 12
IQ - Iraq 11
PL - Polonia 11
TR - Turchia 11
ES - Italia 10
AU - Australia 9
EC - Ecuador 9
PK - Pakistan 9
AT - Austria 8
LT - Lituania 7
PH - Filippine 7
UZ - Uzbekistan 7
PE - Perù 6
IL - Israele 5
MA - Marocco 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
KE - Kenya 4
MU - Mauritius 4
UY - Uruguay 4
AZ - Azerbaigian 3
CL - Cile 3
JO - Giordania 3
KG - Kirghizistan 3
KR - Corea 3
MY - Malesia 3
PY - Paraguay 3
TH - Thailandia 3
CG - Congo 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
ID - Indonesia 2
JM - Giamaica 2
LK - Sri Lanka 2
LV - Lettonia 2
PA - Panama 2
SI - Slovenia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GN - Guinea 1
GT - Guatemala 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 4.760
Città #
Dublin 264
Ashburn 247
San Jose 247
Chandler 204
Singapore 202
Hong Kong 159
Beijing 149
Dallas 121
Boardman 91
Council Bluffs 71
Ho Chi Minh City 71
Johannesburg 66
Helsinki 53
Ann Arbor 52
Los Angeles 52
Hanoi 49
Lauterbourg 49
Munich 46
Jacksonville 43
Nanjing 41
Princeton 41
Lawrence 40
New York 38
Moscow 34
Medford 30
Shanghai 30
Turku 27
Redondo Beach 26
Wilmington 26
Hebei 24
Changsha 22
Milan 22
Buffalo 20
Santa Clara 19
Nanchang 18
Brussels 17
Orem 17
Pavia 17
São Paulo 17
Brno 16
Woodbridge 15
Brooklyn 13
Frankfurt am Main 13
Phoenix 13
Piscataway 13
The Dalles 13
Toronto 13
Chicago 12
Houston 12
Shenyang 12
Da Nang 11
Tokyo 11
Warsaw 11
Columbus 10
Jiaxing 10
Mexico City 10
Montreal 10
Rome 10
Seattle 9
Atlanta 8
San Francisco 8
Tianjin 8
Baghdad 7
Boston 7
Chennai 7
Nuremberg 7
Stockholm 7
Denver 6
Dhaka 6
Guangzhou 6
Haiphong 6
Hangzhou 6
Istanbul 6
Rio de Janeiro 6
Biên Hòa 5
Bologna 5
Brasília 5
Campinas 5
Florence 5
Manchester 5
Medellín 5
Mumbai 5
Nha Trang 5
Norwalk 5
Poplar 5
Tashkent 5
Turin 5
Washington 5
Wuhan 5
Amsterdam 4
Bắc Ninh 4
Curitiba 4
Fairfield 4
Falkenstein 4
Giv‘atayim 4
Guarulhos 4
Lima 4
London 4
Melbourne 4
Nairobi 4
Totale 3.219
Nome #
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 172
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 166
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 162
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. on behalf of the SOPHIE Study Group. 132
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 132
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 128
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 119
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 116
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe 116
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease 114
Development and validation of an HPLC-UV assay for the therapeutic monitoring of the new antiepileptic drug perampanel in human plasma 112
2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors 108
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 107
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 101
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 98
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 97
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 97
Novel treatment options for epilepsy: Focus on perampanel 96
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 96
Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique 95
Fate of melatonin orally administered in preterm newborns: Antioxidant performance and basis for neuroprotection 95
Challenges in the clinical development of new antiepileptic drugs 95
Antiepileptic drugs and brain maturation: Fetal exposure to lamotrigine generates cortical malformations in rats. 95
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects 95
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 95
Analysis of nocebo effects of antiepileptic drugs across different conditions 94
Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies 92
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research 90
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 89
Melatonin versus Sleep Deprivation for Sleep Induction in Nap Electroencephalography: Protocol for a Prospective Randomized Crossover Trial in Children and Young Adults with Epilepsy 87
Author Response: Does Screening for Adverse Effects Improve Health Outcomes in Epilepsy? A Randomized Trial 86
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats 82
null 80
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations 80
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 80
The pharmacogenomics of epilepsy 79
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy 77
On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva 73
Zonisamide in the management of epilepsy in the elderly 68
Profile of pitolisant in the management of narcolepsy: Design, development, and place in therapy 62
The adverse event profile of levetiracetam: A meta-analysis on children and adults 61
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures 58
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy 56
Straightforward access to 2,3- and 3,4-unsaturated derivatives of N-glycolylneuraminic acid 56
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 55
Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies 53
Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring 48
Tolerability of new antiepileptic drugs: a network meta-analysis 47
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy 45
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 45
Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 43
Solubility of lamotrigine in age-specific biorelevant media that simulated the fasted- and fed-conditions of the gastric and intestinal environments in pediatrics and adults: implications for traditional, re-formulated, modified, and new oral formulations 40
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 38
Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications 38
Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy 36
The effects of daylight saving time and clock time transitions on sleep and sleepiness: a systematic review 32
Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study 31
Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule 10
Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy 5
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 3
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 2
Corpus callosum agenesis: does sleep matter? 2
Totale 4.862
Categoria #
all - tutte 22.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 2 7 2 2 1 2 7 11 5 32 98
2022/2023640 80 62 5 35 54 44 0 36 288 7 21 8
2023/2024301 49 24 14 23 28 67 14 32 2 9 26 13
2024/2025894 41 55 19 17 19 75 57 41 237 33 113 187
2025/20262.219 155 135 208 202 290 86 426 160 217 141 112 87
2026/2027163 79 84 0 0 0 0 0 0 0 0 0 0
Totale 4.862